[HTML][HTML] The lancet global health commission on global eye health: vision beyond 2020
MJ Burton, J Ramke, AP Marques… - The Lancet Global …, 2021 - thelancet.com
Eye health and vision have widespread and profound implications for many aspects of life,
health, sustainable development, and the economy. Yet nowadays, many people, families …
health, sustainable development, and the economy. Yet nowadays, many people, families …
Evidence-based guidelines and secondary meta-analysis for the use of transcranial direct current stimulation in neurological and psychiatric disorders
F Fregni, MM El-Hagrassy… - International Journal …, 2021 - academic.oup.com
Background Transcranial direct current stimulation has shown promising clinical results,
leading to increased demand for an evidence-based review on its clinical effects. Objective …
leading to increased demand for an evidence-based review on its clinical effects. Objective …
[HTML][HTML] Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
Background To contribute to the WHO initiative, VISION 2020: The Right to Sight, an
assessment of global vision impairment in 2020 and temporal change is needed. We aimed …
assessment of global vision impairment in 2020 and temporal change is needed. We aimed …
[HTML][HTML] The hidden burden of eating disorders: an extension of estimates from the Global Burden of Disease Study 2019
Background Anorexia nervosa and bulimia nervosa are the only eating disorders included in
the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, yet binge …
the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, yet binge …
[HTML][HTML] Methods for the economic evaluation of health care interventions for priority setting in the health system: an update from WHO CHOICE
MY Bertram, JA Lauer, K Stenberg… - International Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract The World Health Organization's (WHO's) Choosing Interventions that are Cost-
Effective (CHOICE) programme has been a global leader in the field of economic evaluation …
Effective (CHOICE) programme has been a global leader in the field of economic evaluation …
Years of good life is a well-being indicator designed to serve research on sustainability
Sustainable development (SD) as popularized by the Brundtland Commission and politically
enshrined in the Sustainable Development Goals has been the explicit focus of …
enshrined in the Sustainable Development Goals has been the explicit focus of …
ROS-responsive nanoparticle as a berberine carrier for OHC-targeted therapy of noise-induced hearing loss
Z Zhao, Z Han, K Naveena, G Lei, S Qiu… - … Applied Materials & …, 2021 - ACS Publications
Overproduction of reactive oxygen species (ROS) and inflammation are two key
pathogeneses of noise-induced hearing loss (NIHL), which leads to outer hair cell (OHC) …
pathogeneses of noise-induced hearing loss (NIHL), which leads to outer hair cell (OHC) …
[HTML][HTML] The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for …
NVS Vinkeles Melchers, WA Stolk… - PLoS Neglected …, 2021 - journals.plos.org
Background Onchocerciasis (“river blindness”) can cause severe morbidity, including vision
loss and various skin manifestations, and is targeted for elimination using ivermectin mass …
loss and various skin manifestations, and is targeted for elimination using ivermectin mass …
[HTML][HTML] Cost-effectiveness of population level and individual level interventions to combat non-communicable disease in Eastern Sub-Saharan Africa and South East …
Background: To determine the health system costs and health-related benefits of
interventions for the prevention and control of non-communicable diseases (NCDs) …
interventions for the prevention and control of non-communicable diseases (NCDs) …
Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis
G Health - The Lancet Diabetes & Endocrinology, 2021 - Elsevier
Background For patients with type 2 diabetes in low-income and middle-income countries
(LMICs), access to newer antidiabetic drugs (eg, sodium–glucose co-transporter-2 [SGLT2] …
(LMICs), access to newer antidiabetic drugs (eg, sodium–glucose co-transporter-2 [SGLT2] …